References
- Behan P. O. Pizotifen in the treatment of severe recurrent headache. Single and divided dose therapy compared. Br. J. Clin. Pract. 1982; 36: 13–171. Behan P. O. Pizotifen in the treatment of severe recurrent headache. Single and divided dose therapy compared. Br. J. Clin. Pract. 1982; 36: 13–17
- Carroll J. D., Maclay W. P. Pizotifen (BC105) in migraine prophylaxis. Curr. Med. Res. Opin. 1975; 3: 68–712. Carroll J. D., Maclay W. P. Pizotifen (BC105) in migraine prophylaxis. Curr. Med. Res. Opin. 1975; 3: 68–71
- Foster J. B. Further experience with pizotifen in the treatment of migraine. Curr. Ther. Res. 1976; 19: 66–693. Foster J. B. Further experience with pizotifen in the treatment of migraine. Curr. Ther. Res. 1976; 19: 66–69
- Heathfield K. W. G., Stone P., Crowder D. Pizotifen in the treatment of migraine. Practitioner 1977; 218: 428–4304. Heathfield K. W. G., Stone P., Crowder D. Pizotifen in the treatment of migraine. Practitioner 1977; 218: 428–430
- Hughes R. C., Foster J. B. BC105 in the prophylaxis of migraine. Curr. Ther. Res. 1971; 13: 63–685. Hughes R. C., Foster J. B. BC105 in the prophylaxis of migraine. Curr. Ther. Res. 1971; 13: 63–68
- Lawrence E. R., Hossain M., Littlestone W. Sanomigran for migraine prophylaxis; controlled multi-centre trial in general practice. Headache 1977; 17: 109–1126. Lawrence E. R., Hossain M., Littlestone W. Sanomigran for migraine prophylaxis; controlled multi-centre trial in general practice. Headache 1977; 17: 109–112
- Maclay W. P., Crowder D., Spiro S., Turner P. Postmarketing surveillance: practical experience with ketotifen. Br. Med. J. 1984; 288: 911–9147. Maclay W. P., Crowder D., Spiro S., Turner P. Postmarketing surveillance: practical experience with ketotifen. Br. Med. J. 1984; 288: 911–914
- Mazal S., Rachmilewitz E. A. The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients. J. Neurol. Neurosurg. Psychiatry 1980; 43: 1137–11408. Mazal S., Rachmilewitz E. A. The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients. J. Neurol. Neurosurg. Psychiatry 1980; 43: 1137–1140
- Meier J., Schreier E. Human plasma levels of some anti-migraine drugs. Headache 1976; 16: 96–1049. Meier J., Schreier E. Human plasma levels of some anti-migraine drugs. Headache 1976; 16: 96–104
- Peet K. M. S. Use of pizotifen in severe migraine: a long-term study. Curr. Med. Res. Opin. 1977; 5: 192–19910. Peet K. M. S. Use of pizotifen in severe migraine: a long-term study. Curr. Med. Res. Opin. 1977; 5: 192–199
- Speight T. M., Avery G. S. Pizotifen (BC105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 1972; 3: 159–20311. Speight T. M., Avery G. S. Pizotifen (BC105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches. Drugs 1972; 3: 159–203
- Waters W. E. Community studies of the prevalence of headache. Headache 1970; 9: 178–18612. Waters W. E. Community studies of the prevalence of headache. Headache 1970; 9: 178–186